“You have a pattern of inattention to human subjects protection requirements.”
— Kaiser Permanente’s Institutional Assessment Board, an unbiased committee required by regulation to make sure affected person security in medical research, to 2 Kaiser researchers whose check of a fish-oil derived drug’s effectiveness in treating respiratory sicknesses was halted after an audit discovered some sufferers being examined had shellfish allergy symptoms and weren’t excluded, placing them in danger.
